Unveiling the Future of Cancer Treatment: SELAS Life Sciences to Showcase Groundbreaking Research at SOHO Annual Meeting
Society of Hematologic Oncology (SOHO) Annual Meeting SELLAS Life Sciences Group, Inc. Poster Presentation on CDK9 Inhibitor New York, Sept. 22, 2022 SELLAS Life Sciences Group, Inc. (NASDAQ: SLS), a leading biopharmaceutical company specializing in cancer therapies, recently announced their upcoming poster presentation at the Society of Hematologic Oncology (SOHO) Annual Meeting. The presentation will…